Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

The formulated gel is a promising treatment for alopecia areata.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

TS-13 speeds up hair regrowth after chemotherapy without affecting treatment effectiveness.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Botulinum neurotoxin A is effective and safe for treating various conditions, but more clinical trials are needed to fully assess its benefits and risks.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Steroid cell tumors in ovaries are rare, can cause hormone changes, and may be cancerous.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Acne patients have higher skin mTORC1 activity, which is reduced by isotretinoin treatment.

The emulgel with Saw Palmetto and Sophora Japonica shows promise for treating hair loss.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

Certain medications can help treat PCOS symptoms, but they aren't FDA-approved for this use.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Tofacitinib may help treat hair loss in children with alopecia areata.

Steroid cell tumors in the ovary are rare, can cause hormone-related symptoms, and require surgery.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.